fashion -WSS

fashion

author：entertainment 2025-09-29 19:57:58 - browse：53356

Adobe

Change Healthcare’s recent cyberattack has hospitals, doctors’ offices, and pharmacies across the country reeling as they struggle to process claims and bill patients. Experts told STAT it’s a glaring example of the risk of consolidation in health care.

Change, which is owned by UnitedHealth Group, is one of the nation’s largest insurance claim processing hubs. A cyberattack, first announced Wednesday, took the entire company’s network down. Hospitals, doctors’ offices, and pharmacies have since resorted to sending claims via fax, validating patients’ insurance over the phone, and watching helplessly as unpaid bills pile up, multiple hospital employees told STAT. In an update Monday, UnitedHealth said it was still working to restore its impacted systems.

Antitrust experts said that the broad repercussions of the Change attack show why putting one conglomerate at the center of multiple health care functions is inherently risky. Vulnerabilities within a single company can be more easily exploited. Change’s massive reach — it connects more than 900,000 physicians, 33,000 pharmacies, and 5,500 hospitals to the insurance companies that pay them — exacerbated the disruption, they said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Biotech companies concerned about China biosecurity crackdown

focus

WSS

AI models in health care face new federal disclosure requirements

Chemotherapy shortages won’t get better under Biden’s latest plan

FogPharma raises $145 million in rare Series E round

Readout LOUD Podcast: Legal insider trading, booming biotech stocks

The woman behind the Dana Farber

Pharma patents targeted by Biden in move to slash drug prices

focus

fashion

knowledge

Medicare details structure of new drug price negotiation program

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

23andMe had bad news about my health. I wish a person had delivered it

Chemotherapy shortages won’t get better under Biden’s latest plan

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Supreme Court wrestles with OxyContin maker's bankruptcy deal

The cancer drug shortage isn’t new — and neither are the solutions

Pregnancy discrimination could be enabled by AI

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Roche to buy Carmot Therapeutics, developer of obesity drugs

Wikipedia

Sanofi says it has 12 blockbusters on the way. Will investors believe it?

AI models in health care face new federal disclosure requirements

Kenai launches with $82 million for Parkinson’s stem cell therapy

Scientists unlock the key to scar

FDA approves world's first CRISPR

What PEPFAR has meant on the ground in Ukraine

focus

entertainment

focus

Wikipedia